• Enovis posted Q2 net sales of $583 million, up 3% year over year on a reported basis, with organic growth of 5%.
• GAAP net loss narrowed to $1 million, or $0.02 per share, from a larger loss a year earlier.
• Non-GAAP adjusted EBITDA rose to $104 million, lifting margin to 17.9% from 16.2%.
• Reconstructive net sales climbed 8% reported, while Prevention & Recovery net sales slipped 1% reported.
• Maintained full-year 2026 outlook, including revenue of $2.31 billion-$2.37 billion, adjusted EBITDA of $425 million-$435 million, adjusted EPS of $3.52-$3.73.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enovis Corporation published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.